Frontlight ResearchEarly access
Thalassaemia trials in United States
9 of 28 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleCollection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
- Where
- Bethesda
- Age
- 18 years to 70 years
- People
- 300
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT03937817 - No phaseTaking peopleInternational Registry of Patients With Alpha Thalassemia
- Where
- San Francisco
- People
- 500
- Run by
- University of California, San Francisco
See details and how to joinNCT04872179 - No phaseTaking peopleATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Where
- Akron, Albuquerque, Atlanta, Austin, Baltimore, Boston, Buffalo, Chapel Hill, Charlotte, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Dayton, Detroit, Gainesville, Green Bay, Greenville, Hartford, Houston, Hyde Park, Indianapolis, Iowa City, Kansas City, Las Vegas, Little Rock, Los Angeles, Memphis, Miami, Milwaukee, Nashville, Newark, New Haven, New Orleans, New York, Norfolk, Oakland, Orlando, Peoria, Philadelphia, Phoenix, Pittsburgh, Providence, Reno, Rochester, Sacramento, San Antonio, San Bernardino, San Diego, San Francisco, Savannah, Scarborough, Seattle, St Louis, St. Petersburg, Tampa, The Bronx, Toledo, Washington D.C., Wilmington, Winston-Salem
- People
- 3,000
- Run by
- American Thrombosis and Hemostasis Network
See details and how to joinNCT04398628 - No phaseTaking peopleSickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
- Where
- Memphis
- Age
- 13 years and over
- People
- 352
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04416178 - No phaseTaking peopleData Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- Where
- Pittsburgh
- Age
- 2 months to 60 years
- People
- 50
- Run by
- Paul Szabolcs
See details and how to joinNCT04528355 - No phaseEnrolling by invitationA Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
- Where
- Atlanta, Aurora, Charleston, Charlotte, Cleveland, Columbus, Dallas, Fort Worth, Minneapolis, Nashville, New Haven, New York, Oakland, Philadelphia, St. Petersburg
- Age
- 12 years to 50 years
- People
- 54 worldwide
- Run by
- Editas Medicine, Inc.
See details and how to joinNCT06363760 - No phaseTaking peopleA Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- Where
- Houston, Minneapolis, New Hyde Park, Oakland, Palo Alto, Philadelphia
- People
- 150
- Run by
- Genetix Biotherapeutics Inc.
See details and how to joinNCT06271512 - No phaseEnrolling by invitationDecision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 100
- Run by
- Georgetown University
See details and how to joinNCT06664541 - No phaseTaking peopleStudy of the Role of Genetic Modifiers in Hemoglobinopathies
- Where
- Boston
- Age
- 2 years and over
- People
- 30,000 worldwide
- Run by
- Cyprus Institute of Neurology and Genetics
See details and how to joinNCT05799118